Endometrial Hyperplasia Risk in Relation to Recent Use of Oral Contraceptives and Hormone Therapy
- 31 January 2009
- journal article
- Published by Elsevier BV in Annals of Epidemiology
- Vol. 19 (1), 1-7
- https://doi.org/10.1016/j.annepidem.2008.08.099
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Risk of Complex and Atypical Endometrial Hyperplasia in Relation to Anthropometric Measures and Reproductive HistoryAmerican Journal of Epidemiology, 2008
- Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health planBritish Journal of Cancer, 2007
- Antifibrinolytics for heavy menstrual bleedingCochrane Database of Systematic Reviews, 2000
- Norethindrone acetate and estradiol-induced endometrial hyperplasiaPublished by Ovid Technologies (Wolters Kluwer Health) ,2000
- Hormonal Pathology of the EndometriumLaboratory Investigation, 2000
- Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleedingPublished by Wiley ,1999
- The Prognostic and Therapeutic Implications of Cytologic Atypia in Patients with Endometrial HyperplasiaGynecologic Oncology, 1994
- Postmenopausal unopposed estrogens characteristics of use in relation to the risk of endometrial carcinomaAnnals of Epidemiology, 1993
- Effects of Estrogens and Progestins on the Biochemistry and Morphology of the Postmenopausal EndometriumNew England Journal of Medicine, 1981
- Decreased Risk of Endometrial Cancer among Oral-Contraceptive UsersNew England Journal of Medicine, 1980